Sfoglia per Autore
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production
2015-01-01 Larussa, Tiziana; Leone, Isabella; Suraci, Evelina; Nazionale, Immacolata; Procopio, Teresa; Conforti, Francesco; MONTEBIANCO ABENAVOLI, Ludovico; L Hribal, Marta; Imeneo, Maria; Luzza, Francesco
OLEUROPEIN EXERTS ANTIOXIDANT ACTIVITY AND REDUCES THE EXPRESSION OF COX-2 AND PROINFLAMMATORY CYTOKINES IN CACO-2 CELLS AND COLONIC MUCOSA FROM ULCERATIVE COLITIS PATIENTS
2015-01-01 Larussa, T; Trapasso, E; Greco, M; Oliverio, M; Leone, I; Paolino, D; Suraci, E; Imeneo, M; Bonacci, S; Accattato, F; Procopio, A; Fresta, M; Gulletta, E; Luzza, F
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance
2015-01-01 Larussa, T; Leone, I; Suraci, E; Imeneo, M; Luzza, F
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial
2015-01-01 Compare, D; Rocco, A; Sgamato, C; Coccoli, P; Campo, Sm; Nazionale, I; Larussa, T; Luzza, F; Chiodini, P; Nardone, G.
Enhanced Expression of Indoleamine 2,3-Dioxygenase (IDO) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates TH1/Th2 Pathway and Interleukin (IL)-17 Production.
2016-01-01 Larussa, T.; Leone, I.; Suraci, E.; Nazionale, I.; Procopio, T.; Conforti, F.; Montebianco Abenavoli, L; Hribal, M. L.; Imeneo, M.; Luzza, F.
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease.
2016-01-01 Montebianco Abenavoli, L; Milic, N; Larussa, T; Suraci, E; Imeneo, G; Medic, M; Luzza, F
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients
2017-01-01 Larussa, T; Oliverio, M; Suraci, E; Greco, M; Placida, R; Gervasi, S; Marasco, R; Imeneo, M; Paolino, D; Tucci, L; Gulletta, E; Fresta, M; Procopio, A; Luzza, F
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients
2017-01-01 Larussa, Tiziana; Oliverio, M; Suraci, E; Greco, M; Placida, R; Gervasi, S; Marasco, R; Imeneo, M; Paolino, D; Tucci, L; Gulletta, E; Fresta, M; Procopio, A; Luzza, F
Normal Bone Mineral Density Associates with Duodenal Mucosa Healing in Adult Patients with Celiac Disease on a Gluten-Free Diet
2017-01-01 Larussa, T; Suraci, E; Imeneo, M; Marasco, R; Luzza, F
Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection
2017-01-01 Nemati, M.; Larussa, T.; Khorramdelazad, H.; Mahmoodi, M.; Jafarzadeh, A.
Potential role of nutraceutical compounds in inflammatory bowel disease
2017-01-01 Larussa, T; Imeneo, M; Luzza, F
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers
2017-01-01 Tursi, A; Allegretta, L; Buccianti, N; DELLA VALLE, N; Elisei, W; Forti, G; Faggiani, R; Gallina, S; Hadad, Y; Larussa, T; Lauria, A; Luzza, F; Lorenzetti, R; Mocci, G; Penna, A; Polimeni, N; Pranzo, G; Ricciardelli, C; Zampaletta, C; Picchio, M
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers
2018-01-01 Tursi, A; Elisei, W; Faggiani, R; Allegretta, L; Valle, Nd; Forti, G; Franceschi, M; Ferronato, A; Gallina, S; Larussa, T; Luzza, F; Lorenzetti, R; Mocci, G; Penna, A; Rodino', S; Sebkova, L; DE MEDICI, A; Pranzo, G; Ricciardelli, C; Grasso, G; Scorza, S; Zampaletta, C; Picchio, M
Diminished circulating concentration of interleukin-35 in Helicobacter pylori-infected patients with peptic ulcer: Its association with FOXP3 gene polymorphism, bacterial virulence factor CagA, and gender of patients
2018-01-01 Bassagh, A.; Hayatbakhsh Abasi, M.; Larussa, T.; Ghazizadeh, M.; Nemati, M.; Mirkamandar, E.; Jafarzadeh, A.
Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori
2018-01-01 Larussa, T; Gervasi, S; Liparoti, R; Suraci, E; Marasco, R; Imeneo, M; Luzza, F
T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection
2018-01-01 Jafarzadeh, A.; Larussa, T.; Nemati, M.; Jalapour, S.
Very low vitamin D level is an independent risk factor for bone demineralization in IBD patients
2019-01-01 Larussa, T; Suraci, E; Montalcini, T; Nazionale, I; Montebianco Abenavoli, L; Imeneo, M; Luzza, F
Living with inflammatory bowel diseases: patients’ perceptions and unmet needs from a single-center Italian survey
2019-01-01 Larussa, T; Flauti, D; Suraci, E; Imeneo, M; Marasco, R; Montebianco Abenavoli, L; Luzza, F
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization
2019-01-01 Larussa, T; Suraci, E; Marasco, R; Imeneo, M; Abenavoli, L; Luzza, F
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers
2019-01-01 Tursi, A; Mocci, G; Faggiani, R; Allegretta, L; Valle, Nd; Forti, G; Franceschi, M; Ferronato, A; Gallina, S; Larussa, T; Luzza, F; Lorenzetti, R; Penna, A; Rodino, S; Sebkova, L; Lauria, A; Piergallini, S; Pranzo, G; Ricciardelli, C; Zampaletta, C; Elisei, W; Picchio, M
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production | 1-gen-2015 | Larussa, Tiziana; Leone, Isabella; Suraci, Evelina; Nazionale, Immacolata; Procopio, Teresa; Conforti, Francesco; MONTEBIANCO ABENAVOLI, Ludovico; L Hribal, Marta; Imeneo, Maria; Luzza, Francesco | |
OLEUROPEIN EXERTS ANTIOXIDANT ACTIVITY AND REDUCES THE EXPRESSION OF COX-2 AND PROINFLAMMATORY CYTOKINES IN CACO-2 CELLS AND COLONIC MUCOSA FROM ULCERATIVE COLITIS PATIENTS | 1-gen-2015 | Larussa, T; Trapasso, E; Greco, M; Oliverio, M; Leone, I; Paolino, D; Suraci, E; Imeneo, M; Bonacci, S; Accattato, F; Procopio, A; Fresta, M; Gulletta, E; Luzza, F | |
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance | 1-gen-2015 | Larussa, T; Leone, I; Suraci, E; Imeneo, M; Luzza, F | |
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial | 1-gen-2015 | Compare, D; Rocco, A; Sgamato, C; Coccoli, P; Campo, Sm; Nazionale, I; Larussa, T; Luzza, F; Chiodini, P; Nardone, G. | |
Enhanced Expression of Indoleamine 2,3-Dioxygenase (IDO) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates TH1/Th2 Pathway and Interleukin (IL)-17 Production. | 1-gen-2016 | Larussa, T.; Leone, I.; Suraci, E.; Nazionale, I.; Procopio, T.; Conforti, F.; Montebianco Abenavoli, L; Hribal, M. L.; Imeneo, M.; Luzza, F. | |
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. | 1-gen-2016 | Montebianco Abenavoli, L; Milic, N; Larussa, T; Suraci, E; Imeneo, G; Medic, M; Luzza, F | |
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients | 1-gen-2017 | Larussa, T; Oliverio, M; Suraci, E; Greco, M; Placida, R; Gervasi, S; Marasco, R; Imeneo, M; Paolino, D; Tucci, L; Gulletta, E; Fresta, M; Procopio, A; Luzza, F | |
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients | 1-gen-2017 | Larussa, Tiziana; Oliverio, M; Suraci, E; Greco, M; Placida, R; Gervasi, S; Marasco, R; Imeneo, M; Paolino, D; Tucci, L; Gulletta, E; Fresta, M; Procopio, A; Luzza, F | |
Normal Bone Mineral Density Associates with Duodenal Mucosa Healing in Adult Patients with Celiac Disease on a Gluten-Free Diet | 1-gen-2017 | Larussa, T; Suraci, E; Imeneo, M; Marasco, R; Luzza, F | |
Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection | 1-gen-2017 | Nemati, M.; Larussa, T.; Khorramdelazad, H.; Mahmoodi, M.; Jafarzadeh, A. | |
Potential role of nutraceutical compounds in inflammatory bowel disease | 1-gen-2017 | Larussa, T; Imeneo, M; Luzza, F | |
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers | 1-gen-2017 | Tursi, A; Allegretta, L; Buccianti, N; DELLA VALLE, N; Elisei, W; Forti, G; Faggiani, R; Gallina, S; Hadad, Y; Larussa, T; Lauria, A; Luzza, F; Lorenzetti, R; Mocci, G; Penna, A; Polimeni, N; Pranzo, G; Ricciardelli, C; Zampaletta, C; Picchio, M | |
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers | 1-gen-2018 | Tursi, A; Elisei, W; Faggiani, R; Allegretta, L; Valle, Nd; Forti, G; Franceschi, M; Ferronato, A; Gallina, S; Larussa, T; Luzza, F; Lorenzetti, R; Mocci, G; Penna, A; Rodino', S; Sebkova, L; DE MEDICI, A; Pranzo, G; Ricciardelli, C; Grasso, G; Scorza, S; Zampaletta, C; Picchio, M | |
Diminished circulating concentration of interleukin-35 in Helicobacter pylori-infected patients with peptic ulcer: Its association with FOXP3 gene polymorphism, bacterial virulence factor CagA, and gender of patients | 1-gen-2018 | Bassagh, A.; Hayatbakhsh Abasi, M.; Larussa, T.; Ghazizadeh, M.; Nemati, M.; Mirkamandar, E.; Jafarzadeh, A. | |
Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori | 1-gen-2018 | Larussa, T; Gervasi, S; Liparoti, R; Suraci, E; Marasco, R; Imeneo, M; Luzza, F | |
T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection | 1-gen-2018 | Jafarzadeh, A.; Larussa, T.; Nemati, M.; Jalapour, S. | |
Very low vitamin D level is an independent risk factor for bone demineralization in IBD patients | 1-gen-2019 | Larussa, T; Suraci, E; Montalcini, T; Nazionale, I; Montebianco Abenavoli, L; Imeneo, M; Luzza, F | |
Living with inflammatory bowel diseases: patients’ perceptions and unmet needs from a single-center Italian survey | 1-gen-2019 | Larussa, T; Flauti, D; Suraci, E; Imeneo, M; Marasco, R; Montebianco Abenavoli, L; Luzza, F | |
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization | 1-gen-2019 | Larussa, T; Suraci, E; Marasco, R; Imeneo, M; Abenavoli, L; Luzza, F | |
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers | 1-gen-2019 | Tursi, A; Mocci, G; Faggiani, R; Allegretta, L; Valle, Nd; Forti, G; Franceschi, M; Ferronato, A; Gallina, S; Larussa, T; Luzza, F; Lorenzetti, R; Penna, A; Rodino, S; Sebkova, L; Lauria, A; Piergallini, S; Pranzo, G; Ricciardelli, C; Zampaletta, C; Elisei, W; Picchio, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile